Overcoming therapy resistance in EGFR-mutant lung cancer

A Passaro, PA Jänne, T Mok, S Peters - Nature Cancer, 2021 - nature.com
Tyrosine kinase inhibitors (TKIs) have dramatically changed the clinical prospects of patients
with non-small cell lung cancer harboring epidermal growth factor receptor (EGFR) …
被引用次数：300 相关文章

Overcoming therapy resistance in EGFR-mutant lung cancer

A Passaro, PA Jänne, T Mok, S Peters - Nature cancer, 2021 - pubmed.ncbi.nlm.nih.gov
Tyrosine kinase inhibitors (TKIs) have dramatically changed the clinical prospects of patients
with non-small cell lung cancer harboring epidermal growth factor receptor (EGFR) …

[引用][C] Overcoming therapy resistance in EGFR-mutant lung cancer

A Passaro, PA Jänne, T Mok, S Peters - Nature Cancer, 2021 - cir.nii.ac.jp
Overcoming therapy resistance in EGFR-mutant lung cancer | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

Overcoming therapy resistance in EGFR-mutant lung cancer.

A Passaro, PA Jänne, T Mok, S Peters - Nature Cancer, 2021 - europepmc.org
Tyrosine kinase inhibitors (TKIs) have dramatically changed the clinical prospects of patients
with non-small cell lung cancer harboring epidermal growth factor receptor (EGFR) …